TY  - JOUR
AU  - Vrancken, Bram
AU  - Cuypers, Lize
AU  - Pérez, Ana Belen
AU  - Chueca, Natalia
AU  - Anton-Basantas, Joaquin
AU  - de la Iglesia, Alberto
AU  - Fuentes, Javier
AU  - Pineda, Juan Antonio
AU  - Téllez, Francisco
AU  - Bernal, Enrique
AU  - Rincón, Pilar
AU  - Von Wichman, Miguel Angel
AU  - Fuentes, Ana
AU  - Vera, Francisco
AU  - Rivero-Juárez, Antonio
AU  - Jiménez, Miguel
AU  - Vandamme, Anne-Mieke
AU  - García, Federico
PY  - 2019
DO  - 10.1016/j.jhep.2019.08.010
SN  - 0168-8278
UR  - http://hdl.handle.net/10668/14584
T2  - Journal of hepatology
AB  - As of 2018, the majority of Western European countries – including Spain – have lifted restrictions to therapy based on disease severity in the context of HCV infections.1 Long overdue, most national elimination programmes now also include access to...
LA  - en
PB  - Elsevier
KW  - Elimination
KW  - European Union
KW  - HCV
KW  - National strategy
KW  - PWID
KW  - Spain
KW  - Antiviral Agents
KW  - Drug Users
KW  - Hepatitis C
KW  - Hepatitis C, Chronic
KW  - Humans
KW  - Opiate Substitution Treatment
KW  - Substance Abuse, Intravenous
TI  - Cross-country migration linked to people who inject drugs challenges the long-term impact of national HCV elimination programmes.
TY  - research article
VL  - 71
ER  -